Recent

% | $
Quotes you view appear here for quick access.

EDAP TMS SA Message Board

termi0209 20 posts  |  Last Activity: Apr 9, 2015 10:21 AM Member since: Dec 25, 2010
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    $4.50 near term price target

    by reinhardtrex Apr 7, 2015 8:22 AM
    termi0209 termi0209 Apr 9, 2015 10:21 AM Flag

    Read the last c.c
    Obviously, before end of 2016 is a mistake, is before end of 2015
    About the PMA you are right, by october 2015.
    About De Novo, they will need more time , and FDA will decide in 120 days, therefore if they need 1-2 adcionales months , we are in the same situation...by october 2015

    From last c.c.
    "We have until April 29 to submit the PMA amendment. We also have the ability to request an extension and we will certainly ask for it as the new and additional pathway, the De Novo petition is taking some time and focus from our team.

    This De Novo petition and process that FDA recommended is a huge opportunity for the company and Ablatherm HIFU. It will most probably accelerate getting our globally recognized and proven technology into the hands of the American urologists and their patients.

    Time wise it is difficult to give an expectation but the next milestone is for us to submit our direct De Novo petition to the agency. We are currently actively working on it and once submitted, the FDA has 120 days to review its end of the stated, although in practice it may take longer to complete the review."

    Sentiment: Strong Buy

  • Reply to

    What if the FDA pushes approval further out?

    by gretzteam Mar 1, 2015 12:56 PM
    termi0209 termi0209 Mar 1, 2015 1:55 PM Flag

    I think that we will see new highs before FDA decision, 7-8$.
    Yes: 15-20$
    No: 1,5-2 $
    1-HIFU works
    2-Ablatherm is approved around the world( Canada approved focal one)
    3- Although the negative ADCOM, FDA couldn´t ignore the reality that they showed in the letter.Ablatherm has to be approved.

    Sentiment: Strong Buy

  • Reply to

    Manipulation again!!!!

    by hhle2014 Feb 27, 2015 4:03 PM
    termi0209 termi0209 Mar 1, 2015 2:06 AM Flag

    It' illegal. I'm 100% sure.You can't mark the close, you can be sure that if you do it many times your broker can close your account.
    We should report to our brokers. I will do.

    Sentiment: Strong Buy

  • Reply to

    More great news!!

    by termi0209 Feb 27, 2015 12:49 PM
    termi0209 termi0209 Feb 28, 2015 1:19 PM Flag

    I read all the article. Only 16 pages...
    Come on edap!! We want 6 $ soon.!!!

    Sentiment: Strong Buy

  • Reply to

    Manipulation again!!!!

    by hhle2014 Feb 27, 2015 4:03 PM
    termi0209 termi0209 Feb 28, 2015 6:52 AM Flag

    HASTA LOS COJONES!!!!The close was a F... JOKE..
    This week has been amazing..last wednesday 3,68 to 3,61, last thursday 3,86 -3,82, on monday and tuesday edap was above 3,6 and closed at 3,56..
    On Monday I will report to my broker what is happening during lasts two months..

    Sentiment: Strong Buy

  • Reply to

    NCT01489787

    by chubby_blow_hard Feb 27, 2015 1:21 PM
    termi0209 termi0209 Feb 27, 2015 1:53 PM Flag

    I´ve been following/trading edap during lasts four years, and I´m convinced that FDA approval will be huge for shareholders..for this reason I´ve bought 40.000 shares.
    If we compare edap with hundreds of bios anything below 500m M.K will be surreal..

    Sentiment: Strong Buy

  • termi0209 by termi0209 Feb 27, 2015 12:49 PM Flag

    The info that found chubby about liver ( project CLARA page 134), was published yesterday...
    You can find all the info in journals.plos.org, but I found it in investorshub.
    Come on edap!! wake up!!this is great!!

    Abstract

    Background

    Surgery is the only curative treatment in patients with colorectal liver metastases (CLM), but only 10–20% of patients are eligible. High Intensity Focused Ultrasound (HIFU) technology is of proven value in several indications, notably prostate cancer. Its intra-operative use in patients with CLM has not previously been studied. Preclinical work suggested the safety and feasibility of a new HIFU device capable of ablating volumes of up to 2cm x 2cm in a few seconds.

    Methods

    We conducted a prospective, single-centre phase I-IIa trial. HIFU was delivered immediately before scheduled hepatectomy. To demonstrate the safety and efficacy of rapidly ablating liver parenchyma, ablations were performed on healthy tissue within the areas scheduled for resection.

    Results

    In total, 30 ablations were carried out in 15 patients. These ablations were all generated within 40 seconds and on average measured 27.5mm x 21.0mm. The phase I study (n = 6) showed that use of the HIFU device was feasible and safe and did not damage neighbouring tissue. The phase IIa study (n = 9) showed both that the area of ablation could be precisely targeted on a previously implanted metallic mark (used to represent a major anatomical structure) and that ablations could be undertaken deliberately to avoid such a mark. Ablations were achieved with a precision of 1–2 mm.

    Conclusion

    HIFU was feasible, safe and effective in ablating areas of liver scheduled for resection. The next stage is a phase IIb study which will attempt ablation of small metastases with a 5 mm margin, again prior to planned resection.

    Sentiment: Strong Buy

  • Reply to

    EDAP $20 this year.....after FDA approval....

    by aeinstein_com Feb 26, 2015 10:35 AM
    termi0209 termi0209 Feb 26, 2015 10:38 AM Flag

    20 $ is only 500 mm.
    Have you seen BIOC ??? +200% in 3 days...we can expect something similar for edap by september/october.,

  • Reply to

    Japan is not approved yet.

    by termi0209 Feb 20, 2015 10:19 AM
    termi0209 termi0209 Feb 20, 2015 11:24 AM Flag

    ¿¿¿Pero que dices???No estoy de acuerdo en lo que escribes.Lee bien los posts , porque no tienen muy claro si hablan de hifu o litho, y no tienen claro si hifu está aprobado o no en Japón.

  • Centres: Info from hifu-planet.

    Austria (1 centro) Belgium (2 centros) Bolivia (1 centro) Brazil (1 centro) Canada (3 centros) Dominican Republic (1 centro) Ecuador (2 centros) Egypt (1 centro) France (37 centros) Germany (49 centros) India (1 centro) Italy (25 centros) Korea (1 centro) Lebanon (1 centro) Mexico (1 centro) Monaco (1 centro) Netherlands (3 centros) Norway (1 centro) Poland (2 centros) Russia (18 centros) South Africa (1 centro) Spain (4 centros) Switzerland (5 centros) Taiwan (16 centros) Thailand (1 centro) Turkey (1 centro) United Arab Emirates (1 centro), U.K 12

    Sentiment: Strong Buy

  • termi0209 termi0209 Feb 18, 2015 2:51 PM Flag

    Probably results Q1/Q2 2016= We will see historical highs in 2016.

    Sentiment: Strong Buy

  • termi0209 termi0209 Feb 18, 2015 1:22 PM Flag

    Great find!!! Edap doen´t say anything.....the question is why???now the same with the HECAM project!!....!why???

    Sentiment: Strong Buy

  • Reply to

    EDAP Partners with GE and seven others.......

    by aeinstein_com Feb 17, 2015 10:15 AM
    termi0209 termi0209 Feb 17, 2015 6:08 PM Flag

    Everyone should ask to edap about the P.R., contact through their website.
    I did it.

    Sentiment: Strong Buy

  • termi0209 by termi0209 Feb 17, 2015 1:09 PM Flag

    I got an answer ...now I asked them about the HECAM project..

    Dear Mr...

    Thank you for your inquiry. Our liver project is ongoing, and we plan to provide updates on new developments as appropriate. At this point, I am unable to provide a specific time estimate for news specifically on the liver trial. We plan to disclose any and all material news related to our business (all aspects of the business), in a timely manner and in accordance with our disclosure obligations as a Nasdaq-listed company.

    Best regards,..

    Sentiment: Strong Buy

  • termi0209 by termi0209 Feb 17, 2015 10:31 AM Flag

    Last friday was amazing for the low volume of this stock.
    10k at 3,50, 10 k at 3,52, 3,54 and 3,55 although these order edap closed at high.
    Now 50 k at 3,70

    Sentiment: Strong Buy

  • Reply to

    edap's new project

    by hhle2014 Feb 14, 2015 6:21 PM
    termi0209 termi0209 Feb 16, 2015 3:37 PM Flag

    Esta noticia ya la puse yo . Sólo por saberlo.¿por qué lo repites?

    Sentiment: Strong Buy

  • Guerbet partners HECAM project

    insert-text-here

    12.02.2015 18:02

    The HECAM(1) project is a #$%$41 million research and development competitiveness project, financed to the tune of #$%$18.2 million as part of the future investments program(2). Its ambition is to develop detection, diagnosis and treatment tools for hepatocellular carcinoma (HCC), in other words primary liver cancer.

    Originally an idea of Claire Corot (Guerbet’s Research & Innovation and Business Development Licensing Director and member of the board of directors of Medicen), the HCC multi-technological approach project was structured by GE Healthcare. Piloted by GE Healthcare, HECAM comprises Guerbet, seven SMEs(3) and three academic partners(4). They provide and develop first-rate scientific and technical competencies within the project.

    The benefit of a collaborative approach for a disease with major health consequences such as HCC is huge. And France has excellent academic, structured research, particularly in the field of medical imaging, paving the way for the emergence of innovative solutions.
    Click here to read the press release (only in french).
    (1) HEpatocellular CArcinoma Multi-technological.
    (2) The program is piloted by the French General Investment Commission (CGI) and operated by Bpifrance. Bpifrance, a subsidiary of the Caisse des Dépôts et de l’État, provides loans, guarantees and capital to companies, from their startup to flotation on the stock market.
    (3) BioPredictive, CarThera and IntegraGen (Greater Paris Region), BioSIMS Technologies (Upper Normandy), Intrasense (Languedoc-Roussillon), EDAP TMS France and Fluoptics (Rhône-Alpes).
    (4) Gustave Roussy, Europe’s leading cancer treatment center, the Paris Public Hospitals Group (with four hospitals: Beaujon, Jean Verdier, Henri Mondor and Paul Brousse) and the French Healthcare and Medical Research Institute (five INSERM units). The consortium is also supported by the Montpellier Regional University Hospital.

    Sentiment: Strong Buy

  • Reply to

    PMA due by April 29th.

    by reinhardtrex Feb 6, 2015 3:44 PM
    termi0209 termi0209 Feb 6, 2015 4:31 PM Flag

    Earnings on February =0% possibilities.Maybe next week we'll know the date. ..earnings on April si o si.

    Sentiment: Strong Buy

  • Reply to

    Up 6% on no news....

    by reinhardtrex Feb 6, 2015 4:00 PM
    termi0209 termi0209 Feb 6, 2015 4:19 PM Flag

    Like always.From 3,47 to 3,44. with 168 Shares sold at 16:00:00 ..lol

    Sentiment: Strong Buy

  • Reply to

    "Painting the Tape"

    by cloudybay Feb 3, 2015 8:43 PM
    termi0209 termi0209 Feb 4, 2015 2:15 PM Flag

    I wrote it the other day.
    EVERYDAY there is a trade at 16:00:00 with about 100-500 shares..and it produces a lower close, it´s amazing because it happens all the sessions.

    Sentiment: Strong Buy

EDAP
3.22+0.02(+0.62%)Apr 17 4:00 PMEDT